Search research articles
Contact Us
Filters
Showing results (91-100 of 112) with videos related to
Page
of 12
Sort By:
Bioorganic & Medicinal Chemistry
|
May 6, 2008
Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives
Silvia Dei, Cristina Bellucci, Michela Buccioni, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2025
Correction to "Study of Chalcogen Aspirin Derivatives with Carbonic Anhydrase Inhibitory Properties for Treating Inflammatory Pain"
Elena Lucarini, Vanessa D'Antongiovanni, Luca Antonioli, et al.
Journal of Medicinal Chemistry
|
January 10, 2023
First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy
Andrea Angeli, Laura Micheli, Fabrizio Carta, et al.
European Journal of Medicinal Chemistry
|
August 17, 2019
Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells
Murat Bozdag, Marta Ferraroni, Carol Ward, et al.
Journal of Medicinal Chemistry
|
October 8, 2024
Benzoxaborinine, New Chemotype for Carbonic Anhydrase Inhibition: <i>Ex Novo</i> Synthesis, Crystallography, <i>In Silico</i> Studies, and Anti-Melanoma Cell Line Activity
Simone Giovannuzzi, Anna Nikitjuka, Andrea Angeli, et al.
Journal of Medicinal Chemistry
|
June 15, 2026
Discovery of Subnanomolar and Highly Selective Carbonic Anhydrase II Inhibitors Featuring L-Shaped Scaffolds via Active-Site-Matched Fragment Growing
Yitong Wang, Alessio Nocentini, Marta Ferraroni, et al.
Journal of Medicinal Chemistry
|
February 20, 2007
Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure
Silvia Dei, Cristina Bellucci, Michela Buccioni, et al.
European Journal of Medicinal Chemistry
|
September 10, 2021
Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action
Damiano Tanini, Simone Carradori, Antonella Capperucci, et al.
European Journal of Medicinal Chemistry
|
October 31, 2025
Production, crystallographic studies, and functional profiling of γ-carbonic anhydrase from the probiotic Limosilactobacillus reuteri: In vitro and cell-based insights
Alessandro Bonardi, Simone Carradori, Niccolò Paoletti, et al.
RSC Medicinal Chemistry
|
June 24, 2024
Benzenesulfonamide decorated dihydropyrimidin(thi)ones: carbonic anhydrase profiling and antiproliferative activity
Hakan Aslan, Gioele Renzi, Andrea Angeli, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 112) with videos related to
Sort By:
Page
of 12
Bioorganic & Medicinal Chemistry
|
May 6, 2008
Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives
Silvia Dei, Cristina Bellucci, Michela Buccioni, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2025
Correction to "Study of Chalcogen Aspirin Derivatives with Carbonic Anhydrase Inhibitory Properties for Treating Inflammatory Pain"
Elena Lucarini, Vanessa D'Antongiovanni, Luca Antonioli, et al.
Journal of Medicinal Chemistry
|
January 10, 2023
First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy
Andrea Angeli, Laura Micheli, Fabrizio Carta, et al.
European Journal of Medicinal Chemistry
|
August 17, 2019
Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells
Murat Bozdag, Marta Ferraroni, Carol Ward, et al.
Journal of Medicinal Chemistry
|
October 8, 2024
Benzoxaborinine, New Chemotype for Carbonic Anhydrase Inhibition: <i>Ex Novo</i> Synthesis, Crystallography, <i>In Silico</i> Studies, and Anti-Melanoma Cell Line Activity
Simone Giovannuzzi, Anna Nikitjuka, Andrea Angeli, et al.
Journal of Medicinal Chemistry
|
June 15, 2026
Discovery of Subnanomolar and Highly Selective Carbonic Anhydrase II Inhibitors Featuring L-Shaped Scaffolds via Active-Site-Matched Fragment Growing
Yitong Wang, Alessio Nocentini, Marta Ferraroni, et al.
Journal of Medicinal Chemistry
|
February 20, 2007
Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure
Silvia Dei, Cristina Bellucci, Michela Buccioni, et al.
European Journal of Medicinal Chemistry
|
September 10, 2021
Chalcogenides-incorporating carbonic anhydrase inhibitors concomitantly reverted oxaliplatin-induced neuropathy and enhanced antiproliferative action
Damiano Tanini, Simone Carradori, Antonella Capperucci, et al.
European Journal of Medicinal Chemistry
|
October 31, 2025
Production, crystallographic studies, and functional profiling of γ-carbonic anhydrase from the probiotic Limosilactobacillus reuteri: In vitro and cell-based insights
Alessandro Bonardi, Simone Carradori, Niccolò Paoletti, et al.
RSC Medicinal Chemistry
|
June 24, 2024
Benzenesulfonamide decorated dihydropyrimidin(thi)ones: carbonic anhydrase profiling and antiproliferative activity
Hakan Aslan, Gioele Renzi, Andrea Angeli, et al.
Page
of 12